| ID | CAS | Name | Synonyms | Molecular Formula | Category |
|---|---|---|---|---|---|
| 1 | 124027-46-9 | CGS 22996 | CGS 22996 11H-[1,2,4]Triazolo[1,5-c][1,3]benzodiazepine, 2-methyl-5-(4-methyl-4-oxido-1-piperazinyl)- | ||
| 2 | 477600-75-2 | Tofacitinib | CP 690550 Tofacitinib 477600-75-2 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile 3-{(3S,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile | ||
| 3 | 1092578-46-5 | (3R,4S)-Tofacitinib | (3R,4S)-Tofacitinib Tofacitinib IMpurity E RS-tofacitinib citirate Tofacitinib Impurity A(3R,4S) (3R,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile (3R,4S)-4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-beta-oxo-1-piperidinepropanenitrile 1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-, (3R,4S)- 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile | ||
| 4 | 1092578-43-2 | Tofacitinib impurity T | Tofacitinib-22 Tofacitinib impurity T Azilsartan medoxomil impurity335 2-cyano-N-methyl-N-((3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl)acetamide Acetamide, 2-cyano-N-methyl-N-[(3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3-piperidinyl]- | ||
| 5 | 28226-14-4 | 1-Triazene, 1,1'-(oxydi-4,1-phenylene)bis[3,3-dimethyl- | 1-Triazene, 1,1'-(oxydi-4,1-phenylene)bis[3,3-dimethyl- | ||
| 6 | 4-AMINO-6-PIPERIDINO-N-(P-TOLYL)-1,3,5-TRIAZINE-2-CARBOXAMIDE | 4-AMINO-6-PIPERIDINO-N-(P-TOLYL)-1,3,5-TRIAZINE-2-CARBOXAMIDE | |||
| 7 | 1,8-DIAMINO-6-ETHOXY-3-PIPERIDIN-1-YL-2,7-NAPHTHYRIDINE-4-CARBONITRILE | 1,8-DIAMINO-6-ETHOXY-3-PIPERIDIN-1-YL-2,7-NAPHTHYRIDINE-4-CARBONITRILE | |||
| 8 | 606104-09-0 | Piperazine, 1-(cyclobutylcarbonyl)-4-(1-phenyl-1H-tetrazol-5-yl)- (9CI) | Methanone, cyclobutyl[4-(1-phenyl-1H-tetrazol-5-yl)-1-piperazinyl]- Piperazine, 1-(cyclobutylcarbonyl)-4-(1-phenyl-1H-tetrazol-5-yl)- (9CI) | ||
| 9 | N-(4-METHYLPHENYL)-5-[(E)-PIPERIDIN-1-YLDIAZENYL]-1H-IMIDAZOLE-4-CARBOXAMIDE | N-(4-METHYLPHENYL)-5-[(E)-PIPERIDIN-1-YLDIAZENYL]-1H-IMIDAZOLE-4-CARBOXAMIDE TOSLAB 818335 | |||
| 10 | 8-Amino-5-methyl-3-(4-methyl-1-piperazinyl)-5H-pyridazino[3,4-b][1,4]benzoxazine | 8-Amino-5-methyl-3-(4-methyl-1-piperazinyl)-5H-pyridazino[3,4-b][1,4]benzoxazine | |||
| 11 | 4-[4-(3-METHOXYPROPYL)-5-METHYL-4H-1,2,4-TRIAZOL-3-YL]-1-PHENYL-1H-PYRAZOL-5-AMINE | 4-[4-(3-METHOXYPROPYL)-5-METHYL-4H-1,2,4-TRIAZOL-3-YL]-1-PHENYL-1H-PYRAZOL-5-AMINE 4-[4-(3-METHOXYPROPYL)-5-METHYL-4H-1,2,4-TRIAZOL-3-YL]-1-PHENYL-1H-PYRAZOL-5-YLAMINE | |||
| 12 | 606108-10-5 | 3H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, N-(3-ethoxypropyl)-3-(phenylmethyl)- (9CI) | 3H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, N-(3-ethoxypropyl)-3-(phenylmethyl)- 3H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, N-(3-ethoxypropyl)-3-(phenylmethyl)- (9CI) | ||
| 13 | 926076-01-9 | N-(1-cyano-1,2-dimethylpropyl)-2-[5-(4-methylphe nyl)-2H-1,2,3,4-tetrazol-2-yl]acetamide | N-(1-cyano-1,2-dimethylpropyl)-2-[5-(4-methylphe nyl)-2H-1,2,3,4-tetrazol-2-yl]acetamide | ||
| 14 | 344418-92-4 | 1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo- | rac-Tofacitinib Tofacitinib Impurity 28 rac-Tofacitinib (Mixture of Diastereomers) Rac-Tofacitinib Citrate (Mixture Of Diastereomers) 4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile 1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo- 3-[4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile | ||
| 15 | 129909-52-0 | 5-METHYL-8-(2-MORPHOLINOETHYL)-7,8-DIHYDRO-6H-PYRAZOLO[1,5-A]PYRROLO[3,2-E]PYRIMIDINE-3-CARBONITRILE | 5-METHYL-8-(2-MORPHOLINOETHYL)-7,8-DIHYDRO-6H-PYRAZOLO[1,5-A]PYRROLO[3,2-E]PYRIMIDINE-3-CARBONITRILE 7-methyl-3-[2-(morpholin-4-yl)ethyl]-1,3,8,12-tetraazatricyclo[7.3.0.0^{2,6}]dodeca-2(6),7,9,11-tetraene-10-carbonitrile 6H-Pyrazolo[1,5-a]pyrrolo[3,2-e]pyrimidine-3-carbonitrile, 7,8-dihydro-5-methyl-8-[2-(4-morpholinyl)ethyl]- | ||
| 16 | 2374700-40-8 | 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile | Azilsartan medoxomil impurity337 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile | ||
| 17 | 2734856-31-4 | 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4S)-rel- | 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4S)-rel- Tofacitinib Impurity 26 |
| ID | CAS | Product Name | Suppliers | Descriptions |
|---|